Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Automated Nucleic Acid Extraction Devices Market Set To Climb From $7.32 Billion In 2026 To $11.05 Billion By 2030
The market size for automated nucleic acid extraction devices has experienced significant growth in recent years. This market is anticipated to expand from $6.6 billion in 2025 to $7.32 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.9%. The growth observed in the past can be credited to the expansion of molecular diagnostic testing, an increase in the prevalence of infectious diseases, higher adoption of laboratory automation, a rise in clinical testing volumes, and advancements in nucleic acid chemistry.
The market for automated nucleic acid extraction devices is projected to experience substantial expansion over the upcoming years, with its size anticipated to reach $11.05 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This projected growth stems from several factors, including a heightened need for swift diagnostic methods, increased funding in genomic studies, the proliferation of personalized medicine diagnostics, wider implementation of point-of-care molecular diagnostic tools, and advancements in extraction efficiency technologies. Key developments anticipated within the forecast timeframe encompass the wider integration of fully automated extraction platforms, a surge in demand for high-throughput molecular diagnostic solutions, increased utilization of integrated sample-to-result systems, the broadening of automated laboratory processes, and a stronger emphasis on preventing contamination during processing.
Get A Free Sample Report With In-Depth Market Insights:
Automated Nucleic Acid Extraction Devices Market Expansion Drivers: What’s Shaping Future Growth?
The future expansion of the automated nucleic acid extraction devices market is expected to be propelled by the increasing incidence of infectious diseases. Such diseases are disorders brought about by pathogenic microorganisms, including bacteria, viruses, fungi, or parasites, capable of direct or indirect transmission between individuals or from animals to humans. A rise in infectious diseases, particularly during widespread health crises like pandemics, escalates the necessity for diagnostic testing. Automated nucleic acid extraction devices are crucial in preparing samples for molecular diagnostics, aiding in the identification of viruses and bacteria. For example, according to GOV.UK, a UK-based public sector information site, in September 2023, tuberculosis (TB) cases in England saw a 7% increase in the first half of 2023 compared to the same period in 2022, with reported cases rising from 2,251 to 2,408. This growing prevalence of infectious diseases is therefore a key factor driving the growth of the automated nucleic acid extraction devices market.
Automated Nucleic Acid Extraction Devices Market Segment Performance And Emerging Opportunities
The automated nucleic acid extraction devices market covered in this report is segmented –
1) By Type: Instruments, Kits, Consumables
2) By Automation Level: Fully Automated, Semi-Automated
3) By End User: Hospitals, Diagnostic Centers, Forensic Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes
Subsegments:
1) By Instruments: Automated Extractors, Liquid Handling Systems
2) By Kits: DNA Extraction Kits, RNA Extraction Kits, Viral Nucleic Acid Extraction Kits
3) By Consumables: Reagents, Columns, Tips And Tubes
Automated Nucleic Acid Extraction Devices Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the automated nucleic acid extraction devices market are actively developing innovative products like automated nucleic acid extraction workstations to cater to a broader customer base, drive increased sales, and boost revenue. An automated nucleic acid extraction workstation functions as a specialized and automated system specifically designed for extracting nucleic acids, such as DNA and RNA, from biological samples. For example, in April 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based supplier of in-vitro diagnostic products, introduced the SAW-48 and Cell Nucleic Acid Extraction Kit (Magnetic Bead Method). The SAW-48 is distinguished as an in-vitro diagnostic medical device that seamlessly combines sample loading, nucleic acid purification, and PCR setup capabilities into a single instrument. This advanced device can process up to 48 samples concurrently, significantly reducing the turnaround time for test results. The SAW-48 streamlines the entire sequence of sample loading, nucleic acid purification, and PCR setup, thereby enhancing the effectiveness of STD and HPV detection. Both the SAW-48 and the Cell Nucleic Acid Extraction Kit collectively provide a comprehensive solution, ensuring a more efficient and simplified process for identifying sexually transmitted diseases and human papillomavirus.
Automated Nucleic Acid Extraction Devices Market Company Landscape And Competitive Strategy
Major companies operating in the automated nucleic acid extraction devices market are QIAGEN N.V., PerkinElmer Inc., F. Hoffmann-La Roche AG, Analytik Jena GmbH, Thermo Fisher Scientific Inc., Accubiomed Co. Ltd., AutoGen Inc., Bioneer Corporation, Tecan Group Ltd., Merck KGaA, Becton Dickinson and Company, DiaSorin Molecular LLC, BioTeke Corporation (Wuxi) Co. Ltd., Xi’an TianLong Science and Technology Co. Ltd., Jiangsu Bioperfectus Technologies Co. Ltd., Hangzhou Bloer Technology Co. Ltd., MGI Tech Co. Ltd., Aurora Biomed Inc., Promega Corporation, Hamilton Company, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Zymo Research Corporation, Agilent Technologies Inc., Danaher Corporation, Eppendorf AG, GE Healthcare Life Sciences, GenScript Biotech Corporation, Greiner Bio-One International GmbH, IntegenX Inc., MicroGEM International Company, Norgen Biotek Corp.
View The Full Automated Nucleic Acid Extraction Devices Market Report:
Automated Nucleic Acid Extraction Devices Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the automated nucleic acid extraction devices market in 2025. The regions covered in the automated nucleic acid extraction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
